BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36372142)

  • 1. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.
    Gannamani V; Varma A; Nathan S; Ustun C
    Transpl Immunol; 2023 Feb; 76():101742. PubMed ID: 36372142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.
    Kawaguchi T; Takeuchi M; Kawajiri C; Abe D; Nagao Y; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
    Transpl Infect Dis; 2013 Apr; 15(2):E54-7. PubMed ID: 23173742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.
    Ongrádi J; Ablashi DV; Yoshikawa T; Stercz B; Ogata M
    J Neurovirol; 2017 Feb; 23(1):1-19. PubMed ID: 27538995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
    Olson AL; Dahi PB; Zheng J; Devlin SM; Lubin M; Gonzales AM; Giralt SA; Perales MA; Papadopoulos EB; Ponce DM; Young JW; Kernan NA; Scaradavou A; O'Reilly RJ; Small TN; Papanicolaou G; Barker JN
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):787-93. PubMed ID: 24548875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.
    Ishiyama K; Katagiri T; Hoshino T; Yoshida T; Yamaguchi M; Nakao S
    Bone Marrow Transplant; 2011 Jun; 46(6):863-9. PubMed ID: 20838386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid.
    Hirabayashi K; Nakazawa Y; Katsuyama Y; Yanagisawa T; Saito S; Yoshikawa K; Shigemura T; Sakashita K; Ichikawa M; Koike K
    Infection; 2013 Feb; 41(1):219-23. PubMed ID: 22971937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
    Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children.
    Chik KW; Chan PK; Li CK; Shing MM; Lee V; Cheng AF; Yuen PM
    Bone Marrow Transplant; 2002 Jun; 29(12):991-4. PubMed ID: 12098068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant].
    Najima Y; Ohashi K; Ando M; Koshida A; Yamashita T; Akiyama H; Sakamaki H
    Rinsho Ketsueki; 2008 Jan; 49(1):40-5. PubMed ID: 18277595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act.
    Zerr DM
    J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S75-S78. PubMed ID: 30590622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
    Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
    Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
    Foppiani L
    Intern Med; 2018 Dec; 57(23):3393-3398. PubMed ID: 29984775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
    Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
    Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective case analysis of antiviral therapies for HHV-6 encephalitis after hematopoietic stem cell transplantation.
    Toomey D; Phan TL; Nguyen V; Phan TT; Ogata M
    Transpl Infect Dis; 2021 Feb; 23(1):e13443. PubMed ID: 32786154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A; McCormick L; Rahman M
    Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis?
    Cheng FW; Lee V; Leung WK; Chan PK; Leung TF; Shing MK; Li CK
    Pediatr Transplant; 2010 Jun; 14(4):483-7. PubMed ID: 19843234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
    Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
    Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ogata M; Oshima K; Ikebe T; Takano K; Kanamori H; Kondo T; Ueda Y; Mori T; Hashimoto H; Ogawa H; Eto T; Ueki T; Miyamoto T; Ichinohe T; Atsuta Y; Fukuda T
    Bone Marrow Transplant; 2017 Nov; 52(11):1563-1570. PubMed ID: 28783148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.